Spyros P Nikas (Spyros Nikas)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Topics

Molecular Dynamics Simulations

Traumatic Brain Injury

Structural Basis

Top Venues

International journal of molecular sciences

Research square

Nature communications

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

David E Gloriam, Thor Thorsen, Yashraj Kulkarni, David A Sykes, Andreas Bøggild, Taner Drace, Pattarin Hompluem, Christos Iliopoulos-Tsoutsouvas, Spyros P Nikas, Henrik Daver, Alexandros Makriyannis, Poul Nissen, Michael Gajhede, Dmitry B Veprintsev, Thomas Boesen, Jette Kastrup
Structural basis of Δ9-THC analog activity at the Cannabinoid 1 receptor. Research square (2024)
David E Gloriam, Thor Thorsen, Yashraj Kulkarni, David A Sykes, Andreas Bøggild, Taner Drace, Pattarin Hompluem, Christos Iliopoulos-Tsoutsouvas, Spyros P Nikas, Henrik Daver, Alexandros Makriyannis, Poul Nissen, Michael Gajhede, Dmitry B Veprintsev, Thomas Boesen, Jette Kastrup
Structural basis of Δ 9 -THC analog activity at the Cannabinoid 1 receptor. Research square (2024)
Spyros P Nikas, Lipin Ji, Yingpeng Liu, Markos-Orestis Georgiadis, Amey Dopeshwarkar, Alex Straiker, Shalley N Kudalkar, Anastasiia V Sadybekov, Michaela Dvorakova, Vsevolod Katritch, Ken Mackie, Lawrence J Marnett, Alexandros Makriyannis
Chiral Me-2-arachidonoyl Glycerols: The First Potent Endocannabinoid Glyceride Templates with Stability to COX-2. ACS medicinal chemistry letters 15 (6) (2024)
Spyros P Nikas, Lipin Ji, Yingpeng Liu, Markos-Orestis Georgiadis, Amey Dopeshwarkar, Alex Straiker, Shalley N Kudalkar, Anastasiia V Sadybekov, Michaela Dvorakova, Vsevolod Katritch, Ken Mackie, Lawrence J Marnett, Alexandros Makriyannis
Chiral Me-2-arachidonoyl Glycerols: The First Potent Endocannabinoid Glyceride Templates with Stability to COX-2. ACS medicinal chemistry letters 15 (6) (2024)
David E Gloriam, Thor Thorsen, Yashraj Kulkarni, David A Sykes, Andreas Bøggild, Taner Drace, Pattarin Hompluem, Christos Iliopoulos-Tsoutsouvas, Spyros P Nikas, Henrik Daver, Alexandros Makriyannis, Poul Nissen, Michael Gajhede, Dmitry B Veprintsev, Thomas Boesen, Jette Kastrup
Structural basis of Δ9-THC analog activity at the Cannabinoid 1 receptor. Research square (2024)
Kaavya Krishna Kumar, Michael J Robertson, Elina Thadhani, Haoqing Wang, Carl-Mikael Suomivuori, Alexander S Powers, Lipin Ji, Spyros P Nikas, Ron O Dror, Asuka Inoue, Alexandros Makriyannis, Georgios Skiniotis, Brian K Kobilka
Structural basis for activation of CB1 by an endocannabinoid analog. Nature communications 14 (1) (2023)
Kaavya Krishna Kumar, Michael J Robertson, Elina Thadhani, Haoqing Wang, Carl-Mikael Suomivuori, Alexander S Powers, Lipin Ji, Spyros P Nikas, Ron O Dror, Asuka Inoue, Alexandros Makriyannis, Georgios Skiniotis, Brian K Kobilka
Structural basis for activation of CB1 by an endocannabinoid analog. Nature communications 14 (1) (2023)
Kaavya Krishna Kumar, Michael J Robertson, Elina Thadhani, Haoqing Wang, Carl-Mikael Suomivuori, Alexander S Powers, Lipin Ji, Spyros P Nikas, Ron O Dror, Asuka Inoue, Alexandros Makriyannis, Georgios Skiniotis, Brian K Kobilka
Structural basis for activation of CB1 by an endocannabinoid analog. Nature communications 14 (1) (2023)
Dimitris Spyridakos, Niki Mastrodimou, Kiran Vemuri, Thanh C Ho, Spyros P Nikas, Alexandros Makriyannis, Kyriaki Thermos
Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats. International journal of molecular sciences 24 (1) (2022)
Dimitris Spyridakos, Niki Mastrodimou, Kiran Vemuri, Thanh C Ho, Spyros P Nikas, Alexandros Makriyannis, Kyriaki Thermos
Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats. International journal of molecular sciences 24 (1) (2022)
Dimitris Spyridakos, Niki Mastrodimou, Kiran Vemuri, Thanh C Ho, Spyros P Nikas, Alexandros Makriyannis, Kyriaki Thermos
Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats. International journal of molecular sciences 24 (1) (2022)
Dimitris Spyridakos, Niki Mastrodimou, Kiran Vemuri, Thanh C Ho, Spyros P Nikas, Alexandros Makriyannis, Kyriaki Thermos
Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats. International journal of molecular sciences 24 (1) (2022)
Dimitris Spyridakos, Niki Mastrodimou, Kiran Vemuri, Thanh C Ho, Spyros P Nikas, Alexandros Makriyannis, Kyriaki Thermos
Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats. International journal of molecular sciences 24 (1) (2022)
Shan Jiang, Christos Iliopoulos-Tsoutsouvas, Fei Tong, Christina A Brust, Catherine M Keenan, Jimit Girish Raghav, Tian Hua, Simiao Wu, Jo-Hao Ho, Yiran Wu, Travis W Grim, Nikolai Zvonok, Ganesh A Thakur, Zhi-Jie Liu, Keith A Sharkey, Laura M Bohn, Spyros P Nikas, Alexandros Makriyannis
Novel Functionalized Cannabinoid Receptor Probes: Development of Exceptionally Potent Agonists. Journal of medicinal chemistry 64 (7) (2021)
Yingpeng Liu, Thanh C Ho, Mohammed Baradwan, Maria Pascual Lopez-Alberca, Christos Illiopoulis-Tsoutsouvas, Spyros P Nikas, Alexandros Makriyannis
Synthesis of Functionalized Cannabilactones. Molecules (Basel, Switzerland) 25 (3) (2020)
Shakiru O Alapafuja, Spyros P Nikas, Thanh C Ho, Fei Tong, Othman Benchama, Alexandros Makriyannis
Chain Substituted Cannabilactones with Selectivity for the CB2 Cannabinoid Receptor. Molecules (Basel, Switzerland) 24 (19) (2019)
Yingpeng Liu, Lipin Ji, Marsha Eno, Shalley Kudalkar, Ai-Ling Li, Marion Schimpgen, Othman Benchama, Paula Morales, Shu Xu, Dow Hurst, Simiao Wu, Khadijah A Mohammad, JodiAnne T Wood, Nikolai Zvonok, Demetris P Papahatjis, Han Zhou, Chandrashekhar Honrao, Ken Mackie, Patricia Reggio, Andrea G Hohmann, Lawrence J Marnett, Alexandros Makriyannis, Spyros P Nikas
( R)- N-(1-Methyl-2-hydroxyethyl)-13-( S)-methyl-arachidonamide (AMG315): A Novel Chiral Potent Endocannabinoid Ligand with Stability to Metabolizing Enzymes. Journal of medicinal chemistry 61 (19) (2018)
Sally Miller, Shashank Kulkarni, Alex Ciesielski, Spyros P Nikas, Ken Mackie, Alexandros Makriyannis, Alex Straiker
Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure. Pharmaceuticals (Basel, Switzerland) 11 (2) (2018)